Related Experiment Video
Updated: Jun 28, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Genomic linkages dictate cancer evolution.
Yifat Bar Or Snarski1, Ofer Shoshani1
1Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Aneuploidy, a state of chromosome imbalance, complicates cancer genomes. This study reveals unique genome network interactions shaping the aneuploid genome in triple-negative breast cancer.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Aneuploidy, characterized by chromosome number imbalance, is a hallmark of cancer, leading to genomic complexity.
- Triple-negative breast cancer (TNBC) frequently exhibits aneuploidy, contributing to its aggressive nature and treatment resistance.
Purpose of the Study:
- To investigate the specific genome network interactions that shape the aneuploid genome in triple-negative breast cancer.
- To elucidate the mechanisms by which chromosome imbalance influences genomic alterations in TNBC.
Main Methods:
- Utilized advanced genomic profiling techniques to analyze DNA from TNBC samples.
- Employed network analysis to identify interactions between genomic regions in aneuploid cells.
- Integrated multi-omics data to understand the functional consequences of aneuploidy.
Main Results:
- Identified novel network interactions specific to the aneuploid state in TNBC.
- Demonstrated that these interactions contribute to the heterogeneity and instability of the TNBC genome.
- Highlighted specific pathways and regulatory elements influenced by chromosome imbalance.
Conclusions:
- The aneuploid genome in TNBC is actively shaped by unique genome network interactions.
- Understanding these interactions provides insights into TNBC pathogenesis and potential therapeutic targets.
- Targeting genome network vulnerabilities may offer new strategies for treating triple-negative breast cancer.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...